𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

✍ Scribed by Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K.; Costabel, Ulrich; Cottin, Vincent; Flaherty, Kevin R.; Hansell, David M.; Inoue, Yoshikazu; Kim, Dong Soon; Kolb, Martin; Nicholson, Andrew G.; Noble, Paul W.; Selman, Moisés; Taniguchi, Hiroyuki; Brun, Michèle; Le Maulf, Florence; Girard, Mannaïg; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Disse, Bernd; Collard, Harold R.

Book ID
124064056
Publisher
Massachusetts Medical Society
Year
2014
Tongue
English
Weight
565 KB
Volume
370
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Nintedanib in Idi
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
✍ Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K. 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 565 KB

In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of disease progression; nintedanib was frequently associated with diarrhea, which led to discontinuation of the study medication in less than 5% of patients.